Documents/HHSFACA852

FACA Committee Purpose & Justification

Strategic_Plan

Start: 2010-10-01, End: 2011-09-30, Publication: 2013-07-09

Source: http://explore.data.gov/resource/datasets/c5i3-bb9j

The information in this plan was imported from the Federal Advisory Committee Act (FACA) database and transformed into StratML Part 1, Strategic Plan, format.

Fiscal Year:2011 Committee Type: Scientific Technical Program Advisory Board

Submitter:

Name:Gannon (J.) Dick

Email:gannon_dick@yahoo.com

Organization:

Name:Center for Substance Abuse Prevention Drug Testing Advisory Board

Acronym:HHS

Description:
[852]: http://www.nac.samhsa.gov/DTAB/index.aspx

Stakeholder(s):

  • Department of Health and Human Services: [32]: http://www.hhs.gov/
    • Sponsoring Agency (Beneficiary)

  • Robert R. Bonds M.H.S.: Engineering and Safety, Amtrak
    • Committee Member (Performer): Special Government Employee (SGE)

  • James A. Bourland Ph.D.: Forensic Toxicologist, Laboratory Director, Ameritox, Ltd.
    • Committee Member (Performer): Special Government Employee (SGE)

  • Larry D. Bowers Ph.D.: Chief Science Officer, United States Anti-Doping Agency
    • Committee Member (Performer): Special Government Employee (SGE)

  • Lawrence S. Brown M.D.: Executive Senior Vice President, Addiction Research & Treatment Corp.
    • Committee Member (Performer): Special Government Employee (SGE)

  • Phyllis K. Chandler: Responsible Person, LabCorp OTS
    • Committee Member (Performer): Special Government Employee (SGE)

  • Janine Denis Cook Ph.D.: Chemist, DWP
    • Committee Member (Performer): Regular Government Employee (RGE)

  • Laurel J. Farrell: Consultant
    • Committee Member (Performer): Special Government Employee (SGE)

  • Courtney H. Lias Ph.D.: Director, Division of Chemistry and Toxicology Devices, U.S. Food and Drug Administration
    • Committee Member (Performer): Ex Officio

  • Barbara J. Rowland M.P.A.: Director, Laboratory Operations, Quest Diagnostics
    • Committee Member (Performer): Special Government Employee (SGE)

  • Donna R. Smith Ph.D.: Program Development and Regulatory Compliance Officer, EDPM
    • Committee Member (Performer): Special Government Employee (SGE)

  • Jim L. Swart M.S.W.: Director, Office of Drug and Alcohol Policy and Compliance, U.S. Department of Transportation
    • Committee Member (Performer): Ex Officio

  • Steven H. Wong Ph.D.: Professor of Pathology and Director, Baptist Medical Center
    • Committee Member (Performer): Special Government Employee (SGE)

Content
Visions
Missions
Values
1: Recommandations